The Heterogeneity of Immune Cell Infiltration Landscape and Its Immunotherapeutic Implications in Hepatocellular Carcinoma

被引:20
作者
Guo, Yuanyuan [1 ,2 ]
Yang, Jing [1 ,2 ]
Ren, Kaidi [1 ,2 ]
Tian, Xueke [1 ,2 ]
Gao, Hua [3 ]
Tian, Xin [1 ,2 ]
Zhang, Xiaojian [1 ,2 ]
Kan, Quancheng [1 ,2 ]
机构
[1] Zhengzhou Univ, Affiliated Hosp 1, Dept Pharm, Zhengzhou, Peoples R China
[2] Zhengzhou Univ, Henan Key Lab Precis Clin Pharm, Zhengzhou, Peoples R China
[3] Zhengzhou Univ, Affiliated Hosp 1, Dept Radiotherapy, Zhengzhou, Peoples R China
关键词
immune cell infiltration; tumor heterogeneity; immune microenvironment; hepatocellular carcinoma; tumor mutational burden; EXPRESSION; CANCER; GRADE;
D O I
10.3389/fimmu.2022.861525
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Immunotherapy, closely associated with immune infiltration and tumor mutation burden (TMB), is emerging as a promising strategy for treating tumors, but its low response rate in hepatocellular carcinoma (HCC) remains a major challenge. Herein, we applied two algorithms to uncover the immune infiltration landscape of the immune microenvironment in 491 HCC patients. Three immune infiltration patterns were defined using the CIBERSORT method, and the immune cell infiltration (ICI) scores were established using principal component analysis. In the high ICI score group, the activation of the Wnt/beta-catenin pathway was significantly enriched and expressions of immune checkpoint genes increased, which showed a pessimistic outcome. The low ICI score group was characterized by increased TMB and enrichment of metabolism-related pathways. Further analysis found that the ICI score exhibited a significant difference in age >= 65/age <65, grade I/grade II-IV, and response to immunotherapy. Moreover, the CTNNB1 mutation status was found to be closely associated with prognosis and immunotherapeutic efficiency, significantly affecting the ICI score and TMB, which might be regarded as a potential marker for the treatment of HCC. The evaluation of immune infiltration patterns can improve the understanding of the tumor immune microenvironment and provide new directions for the study of individualized immunotherapy strategies for HCC.
引用
收藏
页数:14
相关论文
共 46 条
[1]   Conserved pan-cancer microenvironment subtypes predict response to immunotherapy [J].
Bagaev, Alexander ;
Kotlov, Nikita ;
Nomie, Krystle ;
Svekolkin, Viktor ;
Gafurov, Azamat ;
Isaeva, Olga ;
Osokin, Nikita ;
Kozlov, Ivan ;
Frenkel, Felix ;
Gancharova, Olga ;
Almog, Nava ;
Tsiper, Maria ;
Ataullakhanov, Ravshan ;
Fowler, Nathan .
CANCER CELL, 2021, 39 (06) :845-+
[2]   Estimating the population abundance of tissue-infiltrating immune and stromal cell populations using gene expression [J].
Becht, Etienne ;
Giraldo, Nicolas A. ;
Lacroix, Laetitia ;
Buttard, Benedicte ;
Elarouci, Nabila ;
Petitprez, Florent ;
Selves, Janick ;
Laurent-Puig, Pierre ;
Sautes-Fridman, Catherine ;
Fridman, Wolf H. ;
de Reynies, Aurelien .
GENOME BIOLOGY, 2016, 17
[3]   Cold Tumors: A Therapeutic Challenge for Immunotherapy [J].
Bonaventura, Paola ;
Shekarian, Tala ;
Alcazer, Vincent ;
Valladeau-Guilemond, Jenny ;
Valsesia-Wittmann, Sandrine ;
Amigorena, Sebastian ;
Caux, Christophe ;
Depil, Stephane .
FRONTIERS IN IMMUNOLOGY, 2019, 10
[4]  
Bray F, 2018, CA-CANCER J CLIN, V68, P394, DOI [10.3322/caac.21492, 10.3322/caac.21609]
[5]   Tumour microenvironment (TME) characterization identified prognosis and immunotherapy response in muscle-invasive bladder cancer (MIBC) [J].
Cao, Rui ;
Yuan, Lushun ;
Ma, Bo ;
Wang, Gang ;
Tian, Ye .
CANCER IMMUNOLOGY IMMUNOTHERAPY, 2021, 70 (01) :1-18
[6]   Tumor Infiltrating Lymphocytes and CD8+T Cell Subsets as Prognostic Markers in Patients with Surgically Treated Laryngeal Squamous Cell Carcinoma [J].
Chatzopoulos, Kyriakos ;
Kotoula, Vassiliki ;
Manoussou, Kyriaki ;
Markou, Konstantinos ;
Vlachtsis, Konstantinos ;
Angouridakis, Nikolaos ;
Nikolaou, Angelos ;
Vassilakopoulou, Maria ;
Psyrri, Amanda ;
Fountzilas, Georgios .
HEAD & NECK PATHOLOGY, 2020, 14 (03) :689-700
[7]  
Chen H, 2020, AM J SURG PATHOL, V44, P1050, DOI 10.1097/PAS.0000000000001503
[8]   Exosomes: key players in cancer and potential therapeutic strategy [J].
Dai, Jie ;
Su, Yangzhou ;
Zhong, Suye ;
Cong, Li ;
Liu, Bang ;
Yang, Junjun ;
Tao, Yongguang ;
He, Zuping ;
Chen, Chao ;
Jiang, Yiqun .
SIGNAL TRANSDUCTION AND TARGETED THERAPY, 2020, 5 (01)
[9]   The role of PD-L1 expression as a predictive biomarker: an analysis of all US Food and Drug Administration (FDA) approvals of immune checkpoint inhibitors [J].
Davis, Andrew A. ;
Patel, Vaibhav G. .
JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2019, 7 (01)
[10]   Abundant CD8+tumor infiltrating lymphocytes and beta-2-microglobulin are associated with better outcome and response to interleukin-2 therapy in advanced stage clear cell renal cell carcinoma [J].
Davis, Dale ;
Tretiakova, Maria S. ;
Kizzar, Chris ;
Woltjer, Randy ;
Krajbich, Victoria ;
Tykodi, Scott S. ;
Lanciault, Christian ;
Andeen, Nicole K. .
ANNALS OF DIAGNOSTIC PATHOLOGY, 2020, 47